Chemokines in Angiogenesis

被引:74
作者
Dimberg, Anna [1 ]
机构
[1] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden
来源
CHEMOKINE SYSTEM IN EXPERIMENTAL AND CLINICAL HEMATOLOGY | 2010年 / 341卷
关键词
ENDOTHELIAL GROWTH-FACTOR; CELL LUNG-CANCER; PLATELET FACTOR-IV; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B; IN-VIVO; TUMOR ANGIOGENESIS; PROMOTES ANGIOGENESIS; MYELOID CELLS; POTENT INHIBITOR;
D O I
10.1007/82_2010_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chemokines are a family of small heparin-binding proteins, mostly known for their role in inflammation and immune surveillance, which have emerged as important regulators of angiogenesis. Chemokines influence angiogenesis either through recruitment of pro-angiogenic immune cells and endothelial progenitors to the neo-vascular niche or via direct regulation of endothelial function downstream of activation of G-protein coupled chemokine receptors. The dual function of chemokines in regulating immune response and angiogenesis confers a central role in modulating the tissue microenvironment. Therefore, chemokines may constitute attractive targets for therapeutic intervention in several pathological disorders. This review will summarize the current understanding of the role of chemokines in angiogenesis, and give an overview of angiostatic and angiogenic chemokines and their crosstalk with other angiogenic factors.
引用
收藏
页码:59 / 80
页数:22
相关论文
共 122 条
  • [91] Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
    Sgadari, C
    Angiolillo, AL
    Tosato, G
    [J]. BLOOD, 1996, 87 (09) : 3877 - 3882
  • [92] Role of myeloid cells in tumor angiogenesis and growth
    Shojaei, Farbod
    Zhong, Cuiling
    Wu, Xiumin
    Yu, Lanlan
    Ferrara, Napoleone
    [J]. TRENDS IN CELL BIOLOGY, 2008, 18 (08) : 372 - 378
  • [93] Refractoriness to antivascular endothelial growth factor treatment: Role of myeloid cells
    Shojaei, Farbod
    Ferrara, Napoleone
    [J]. CANCER RESEARCH, 2008, 68 (14) : 5501 - 5504
  • [94] Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
    Shojaei, Farbod
    Wu, Xiumin
    Malik, Ajay K.
    Zhong, Cuiling
    Baldwin, Megan E.
    Schanz, Stefanie
    Fuh, Germaine
    Gerber, Hans-Peter
    Ferrara, Napoleone
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (08) : 911 - 920
  • [95] Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7
    Sierro, Frederic
    Biben, Christine
    Martinez-Munoz, Laura
    Mellado, Mario
    Ransohoff, Richard M.
    Li, Meizhang
    Woehl, Blanche
    Leung, Helen
    Groom, Joanna
    Batten, Marcel
    Harvey, Richard P.
    Martinez-A, Carlos
    Mackay, Charles R.
    Mackay, Fabienne
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (37) : 14759 - 14764
  • [96] Chemokines in tumor angiogenesis and metastasis
    Singh, Seema
    Sadanandam, Anguraj
    Singh, Rakesh K.
    [J]. CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) : 453 - 467
  • [97] Host CXCR2-Dependent Regulation of Melanoma Growth, Angiogenesis, and Experimental Lung Metastasis
    Singh, Seema
    Varney, Michelle
    Singh, Rakesh K.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 411 - 415
  • [98] INHIBITION OF INTERLEUKIN-8 ATTENUATES ANGIOGENESIS IN BRONCHOGENIC-CARCINOMA
    SMITH, DR
    POLVERINI, PJ
    KUNKEL, SL
    ORRINGER, MB
    WHYTE, RI
    BURDICK, MD
    WILKE, CA
    STRIETER, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) : 1409 - 1415
  • [99] Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
    Sparmann, A
    Bar-Sagi, D
    [J]. CANCER CELL, 2004, 6 (05) : 447 - 458
  • [100] Chemokines direct endothelial progenitors into tumor neovessels
    Spring, H
    Schüler, T
    Arnold, B
    Hämmerling, GJ
    Ganss, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (50) : 18111 - 18116